Author:
Xu Hui-min,Cai Hong-wen,Dai Hai-bin,Yan Xiao-feng,Zhou Quan,Xu Geng,Huang Zhao-quan,Mao Wei
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Complementary and alternative medicine,General Medicine
Reference19 articles.
1. National Center for Cardiovascular Diseases of China. Report on cardiovascular diseases in China (2010). Beijing: Encyclopedia of China Publishing House; 2011:1.
2. Menzin J, Wygant G, Hauch O, Jackel J, Friedman M. One-year costs of ischemic heart disease among patients with acute coronary syndromes: findings from a multi-employer claims database. Curr Med Res Opin 2008;24:461–468.
3. Smith SC Jr, Allen J, Blair SN, Bonow RO, Brass LM, Fonarow GC, et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. Circulation 2006;113:2363–2372.
4. Smith SC Jr, Benjamin EJ, Bonow RO, Braun LT, Creager MA, Franklin BA, et al. AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation. Circulation 2011;124:2458–2473.
5. The Cardiovascular Branch of Chinese Medical Association, the Editorial Board of Chinese Journal of Cardiology. Chinese guidelines for the diagnosis and management of patients with unstable angina/non ST-segment elevation myocardial infarction. Chin J Cardiol (Chin) 2007;35:295–304.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献